Skip to main content

previous disabled Page of 2
and
  1. No Access

    Article

    Standardized production of hPSC-derived cardiomyocyte aggregates in stirred spinner flasks

    A promising cell-therapy approach for heart failure aims at differentiating human pluripotent stem cells (hPSCs) into functional cardiomyocytes (CMs) in vitro to replace the disease-induced loss of patients’ h...

    Nils Kriedemann, Wiebke Triebert, Jana Teske, Mira Mertens in Nature Protocols (2024)

  2. Article

    Open Access

    Fabrication of heart tubes from iPSC derived cardiomyocytes and human fibrinogen by rotating mold technology

    Due to its structural and functional complexity the heart imposes immense physical, physiological and electromechanical challenges on the engineering of a biological replacement. Therefore, to come closer to c...

    Birgit Andrée, Nils Voß, Nils Kriedemann, Wiebke Triebert, Jana Teske in Scientific Reports (2024)

  3. Article

    Open Access

    Circular RNA circZFPM2 regulates cardiomyocyte hypertrophy and survival

    Hypertrophic cardiomyopathy (HCM) constitutes the most common genetic cardiac disorder. However, current pharmacotherapeutics are mainly symptomatic and only partially address underlying molecular mechanisms. ...

    Dimyana Neufeldt, Arne Schmidt, Elisa Mohr, Dongchao Lu in Basic Research in Cardiology (2024)

  4. Article

    Open Access

    Matrix-free human pluripotent stem cell manufacturing by seed train approach and intermediate cryopreservation

    Human pluripotent stem cells (hPSCs) have an enormous therapeutic potential, but large quantities of cells will need to be supplied by reliable, economically viable production processes. The suspension culture...

    Kevin Ullmann, Felix Manstein, Wiebke Triebert in Stem Cell Research & Therapy (2024)

  5. Article

    Open Access

    Scalable production of tissue-like vascularized liver organoids from human PSCs

    The lack of physiological parity between 2D cell culture and in vivo culture has led to the development of more organotypic models, such as organoids. Organoid models have been developed for a number of tissue...

    Sean P. Harrison, Richard Siller, Yoshiaki Tanaka in Experimental & Molecular Medicine (2023)

  6. Article

    Open Access

    Airway basal cells show a dedifferentiated KRT17highPhenotype and promote fibrosis in idiopathic pulmonary fibrosis

    Idiopathic pulmonary fibrosis (IPF) is a fatal disease with limited treatment options. In this study, we focus on the properties of airway basal cells (ABC) obtained from patients with IPF (IPF-ABC). Single ce...

    Benedikt Jaeger, Jonas Christian Schupp, Linda Plappert in Nature Communications (2022)

  7. No Access

    Article

    Continuous human iPSC-macrophage mass production by suspension culture in stirred tank bioreactors

    Macrophages derived from human induced pluripotent stem cells (iPSCs) have the potential to enable the development of cell-based therapies for numerous disease conditions. We here provide a detailed protocol f...

    Mania Ackermann, Anna Rafiei Hashtchin, Felix Manstein in Nature Protocols (2022)

  8. No Access

    Article

    Generation of heart-forming organoids from human pluripotent stem cells

    Heart-forming organoids (HFOs) derived from human pluripotent stem cells (hPSCs) are a complex, highly structured in vitro model of early heart, foregut and vasculature development. The model represents a pote...

    Lika Drakhlis, Santoshi Biswanath Devadas, Robert Zweigerdt in Nature Protocols (2021)

  9. Article

    Open Access

    Publisher Correction: Human heart-forming organoids recapitulate early heart and foregut development

    Lika Drakhlis, Santoshi Biswanath, Clara-Milena Farr in Nature Biotechnology (2021)

  10. Article

    Open Access

    Human heart-forming organoids recapitulate early heart and foregut development

    Organoid models of early tissue development have been produced for the intestine, brain, kidney and other organs, but similar approaches for the heart have been lacking. Here we generate complex, highly struct...

    Lika Drakhlis, Santoshi Biswanath, Clara-Milena Farr in Nature Biotechnology (2021)

  11. No Access

    Chapter

    Heart Muscle Tissue Engineering

    The human heart is a complex, multicellular organ with limited regenerative capacity. In vitro modeling of the human heart is not only important to better understand the composition and function thereof, but also...

    Michelle Coffee, Santoshi Biswanath in Essential Current Concepts in Stem Cell Bi… (2020)

  12. Article

    Open Access

    Comparing human iPSC-cardiomyocytes versus HEK293T cells unveils disease-causing effects of Brugada mutation A735V of NaV1.5 sodium channels

    Loss-of-function mutations of the SCN5A gene encoding for the sodium channel α-subunit NaV1.5 result in the autosomal dominant hereditary disease Brugada Syndrome (BrS) with a high risk of sudden cardiac death in...

    Jeanne de la Roche, Paweorn Angsutararux, Henning Kempf in Scientific Reports (2019)

  13. Article

    Open Access

    Femtosecond laser-based nanosurgery reveals the endogenous regeneration of single Z-discs including physiological consequences for cardiomyocytes

    A highly organized cytoskeleton architecture is the basis for continuous and controlled contraction in cardiomyocytes (CMs). Abnormalities in cytoskeletal elements, like the Z-disc, are linked to several disea...

    Dominik Müller, Dorian Hagenah, Santoshi Biswanath, Michelle Coffee in Scientific Reports (2019)

  14. No Access

    Protocol

    Evaluating the Effect of Drug Compounds on Cardiac Spheroids Using the Cardiac Cell Outgrowth Assay

    The ideal cell culture model should mimic the cell physiology and the mechanical and the chemical cues that are present in specific tissues and organs, within a convenient high-throughput format. A possible ke...

    Jonas Christoffersson, Florian Meier in Cell-Based Assays Using iPSCs for Drug Dev… (2019)

  15. No Access

    Protocol

    Human Pluripotent Stem Cell Expansion in Stirred Tank Bioreactors

    This chapter describes a detailed protocol on human pluripotent stem cells (hPSCs) cultivation as matrix-free cell-only aggregates in defined and xeno-free culture medium in stirred tank bioreactors (STBRs). S...

    Felix Manstein, Caroline Halloin in Cell-Based Assays Using iPSCs for Drug Dev… (2019)

  16. No Access

    Protocol

    Production of Cardiomyocytes from Human Pluripotent Stem Cells by Bioreactor Technologies

    Cardiomyocytes from human pluripotent stem cells (hPSCs) have the ability to advance specificity of in vitro assays for drug discovery and safety pharmacology. They may also provide a superior cell source for ...

    Caroline Halloin, Michelle Coffee in Cell-Based Assays Using iPSCs for Drug Dev… (2019)

  17. Article

    Open Access

    Bioreactor-based mass production of human iPSC-derived macrophages enables immunotherapies against bacterial airway infections

    The increasing number of severe infections with multi-drug-resistant pathogens worldwide highlights the need for alternative treatment options. Given the pivotal role of phagocytes and especially alveolar macr...

    Mania Ackermann, Henning Kempf, Miriam Hetzel, Christina Hesse in Nature Communications (2018)

  18. Article

    Open Access

    Large-scale production of megakaryocytes in microcarrier-supported stirred suspension bioreactors

    Megakaryocytes (MKs) are the precursors of platelets (PLTs) and may be used for PLT production in vivo or in vitro, as well as a source for PLT-derived growth factors. Induced pluripotent stem cells represent an ...

    Dorothee Eicke, Anja Baigger, Kai Schulze, Sharissa L. Latham in Scientific Reports (2018)

  19. Article

    Open Access

    Expansion of functional personalized cells with specific transgene combinations

    Fundamental research and drug development for personalized medicine necessitates cell cultures from defined genetic backgrounds. However, providing sufficient numbers of authentic cells from individuals poses ...

    Christoph Lipps, Franziska Klein, Tom Wahlicht, Virginia Seiffert in Nature Communications (2018)

  20. No Access

    Book

previous disabled Page of 2